Explore ImmuCell's Q2 2025 earnings: sales growth, improved margins, product expansion, and strategic insights on Re-Tain's FDA approval.

Think of it like this: when Nigeria's economy was hemorrhaging under the previous admin, the Tinubu regime stepped in and controlled the bleeding (aka stabilized the economy). Now, the patient ...